Provided by Tiger Trade Technology Pte. Ltd.

Illumina

130.32
-2.5700-1.93%
Volume:895.06K
Turnover:115.72M
Market Cap:19.91B
PE:23.91
High:131.32
Open:129.69
Low:127.11
Close:132.89
52wk High:155.53
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:0.35
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.45
EPS(LYR):5.45
ROE:33.36%
ROA:8.39%
PB:7.31
PE(LYR):23.91

Loading ...

Illumina price target raised to $120 from $110 at UBS

TIPRANKS
·
Oct 31, 2025

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), Baxter International (BAX) and Illumina (ILMN)

TIPRANKS
·
Oct 31, 2025

Barclays Sticks to Their Sell Rating for Illumina (ILMN)

TIPRANKS
·
Oct 31, 2025

Illumina Shares Rise 6.1% Premarket After Q3 Profit, Revenue Beat Estimates

THOMSON REUTERS
·
Oct 31, 2025

Stock Track | Illumina Surges 6.16% Pre-Market on Strong Q3 Results, Raised Guidance, and Analyst Upgrades

Stock Track
·
Oct 31, 2025

Stock Track | Illumina Surges 6.16% Pre-Market on Strong Q3 Results and Raised 2025 Guidance

Stock Track
·
Oct 31, 2025

Illumina Inc : Canaccord Genuity Raises Target Price to $112 From $105

THOMSON REUTERS
·
Oct 31, 2025

Illumina Reports Steady Q3 2025 Earnings

TIPRANKS
·
Oct 31, 2025

24H | Brighthouse Surges 19%; Illumina Jumps 7%; Lumen Gains 6%; Riot Rises 5%; Roku Sinks 5%

Tiger Newspress
·
Oct 31, 2025

Stock Track | Illumina Soars 7.05% on Strong Q3 Results and Raised Full-Year Guidance

Stock Track
·
Oct 31, 2025

Stock Track | Illumina Soars 7.05% After Smashing Q3 Earnings Expectations and Raising 2025 Guidance

Stock Track
·
Oct 31, 2025

Stock Track | Illumina Soars 5.09% After-Hours on Strong Q3 Results, Raised Guidance

Stock Track
·
Oct 31, 2025

Genomics company Illumina Q3 revenue beats expectations, helped by clinical market growth

Reuters
·
Oct 31, 2025

Illumina Q3 Adj. EPS $1.34 Beats $1.17 Estimate, Sales $1.084B Beat $1.065B Estimate

Benzinga
·
Oct 31, 2025

Illumina Q3 Adjusted EBIT Margin 24.5%

THOMSON REUTERS
·
Oct 31, 2025

Illumina Outlook FY Adjusted EPS USD 4.65-4.75

THOMSON REUTERS
·
Oct 31, 2025

Illumina Q3 EBIT Margin 21%

THOMSON REUTERS
·
Oct 31, 2025

Illumina’s Sequencing Study: A Game Changer in Hematologic Diagnostics?

TIPRANKS
·
Oct 28, 2025

10x sues rival Illumina over gene-sequencing patents

Reuters
·
Oct 22, 2025

JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades'

Benzinga_recent_news
·
Oct 21, 2025